Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SZ-A tablets for early adult LADA
ChiCTR2600135003Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in latent autoimmune diabetes in adults (LADA) comparing SZ-A Treatment Group with Placebo Control Group (2 arms). Primary endpoint: Change from baseline in C-peptide AUC at Week 24. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
ramulus mori alkaloids
03
Conditions
latent autoimmune diabetes in adults (LADA)
Beyond the preview
Go deeper on ChiCTR2600135003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135003.